World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
63
Citations
15786
World Ranking
2710
National Ranking
1091

Shinichi Oka publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Shinichi Oka sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 603 publications — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Shinichi Oka D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Shinichi Oka sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 63 D-Index — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Shinichi Oka is affiliated with Rutgers, The State University of New Jersey in the United States. Their research spans multiple areas within medicine with a primary focus on infectious diseases, immunology, and microbiology.

The scientist has contributed extensively to the fields of HIV research and treatment, including HIV/AIDS interventions and drug development. Their work also covers HIV-related health complications, drug use and sexual risk factors associated with HIV, immune cell function and interaction, and hepatitis C virus research.

Key areas of study include:

  • Medicine
  • Immunology and Microbiology

More specific subfields addressed in their research are:

  • Infectious Diseases
  • Epidemiology
  • Virology
  • Immunology
  • Surgery

Frequent publication venues for their work include:

  • Global Health & Medicine
  • Scientific Reports
  • Journal of Infection and Chemotherapy
  • Journal of Virology
  • bioRxiv (Cold Spring Harbor Laboratory)

Some of their recent papers include:

  • Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection, 2020, New England Journal of Medicine
  • Metagenomic Identification of Microbial Signatures Predicting Pancreatic Cancer From a Multinational Study, 2022, Gastroenterology
  • Long-acting cabotegravir plus rilpivirine for treatment in adults with HIV-1 infection: 96-week results of the randomised, open-label, phase 3 FLAIR study, 2021, The Lancet HIV
  • Population-level Metagenomics Uncovers Distinct Effects of Multiple Medications on the Human Gut Microbiome, 2022, Gastroenterology
  • Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials, 2020, JAIDS Journal of Acquired Immune Deficiency Syndromes

Frequently collaborating coauthors associated with Shinichi Oka include:

  • Hiroyuki Gatanaga
  • Daisuke Mizushima
  • Misao Takano
  • Yoshimi Kikuchi
  • Kôji Watanabe

Best Publications

  • Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials

    Paul E Sax;David Wohl;Michael T Yin;Frank Post

  • Adaptation of HIV-1 to human leukocyte antigen class I

    Y. Kawashima;K. Pfafferott;J. Frater;P. Matthews

  • Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection

    Chloe Orkin;Keikawus Arasteh;Miguel Górgolas Hernández-Mora;Vadim Pokrovsky

  • Homozygous CYP2B6 *6 (Q172H and K262R) correlates with high plasma efavirenz concentrations in HIV-1 patients treated with standard efavirenz-containing regimens.

    Kiyoto Tsuchiya;Hiroyuki Gatanaga;Natsuo Tachikawa;Katsuji Teruya

  • Successful Efavirenz Dose Reduction in HIV Type 1-Infected Individuals with Cytochrome P450 2B6 *6 and *26

    Hiroyuki Gatanaga;Tsunefusa Hayashida;Kiyoto Tsuchiya;Munehiro Yoshino

  • Metagenomic identification of microbial signatures predicting pancreatic cancer from a multinational study.

    Unknown

  • Assessment, Diagnosis, and Treatment of HIV-Associated Neurocognitive Disorder: A Consensus Report of the Mind Exchange Program

    Andrea Antinori;Gabriele Arendt;Igor Grant

  • Brief Report: Randomized, Double-Blind Comparison of Tenofovir Alafenamide (TAF) vs Tenofovir Disoproxil Fumarate (TDF), Each Coformulated With Elvitegravir, Cobicistat, and Emtricitabine (E/C/F) for Initial HIV-1 Treatment: Week 144 Results.

    José R Arribas;Melanie Thompson;Paul E Sax;Bernhard Haas

  • Induction of IFN-λ3 as an additional effect of nucleotide, not nucleoside, analogues: a new potential target for HBV infection.

    Kazumoto Murata;Mai Asano;Akihiro Matsumoto;Masaya Sugiyama

  • Population-level metagenomics uncovers distinct effects of multiple medications on the human gut microbiome.

    Unknown

  • HLA-Cw8 primarily associated with hypersensitivity to nevirapine.

    Hiroyuki Gatanaga;Hirohisa Yazaki;Junko Tanuma;Miwako Honda

  • Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries.

    Dorita Avila;Keri N. Althoff;Catrina Mugglin;Kara Wools-Kaloustian

  • Evaluation of acridinium-ester-labeled DNA probes for identification of Mycobacterium tuberculosis and Mycobacterium avium-Mycobacterium intracellulare complex in culture.

    M Goto;S Oka;K Okuzumi;S Kimura

  • Long-acting cabotegravir plus rilpivirine for treatment in adults with HIV-1 infection: 96-week results of the randomised, open-label, phase 3 FLAIR study

    Chloe Orkin;Shinichi Oka;Patrick Philibert;Cynthia Brinson

  • Outbreak of Pneumocystis jiroveci pneumonia in renal transplant recipients: P. jiroveci is contagious to the susceptible host.

    Hirohisa Yazaki;Norihiko Goto;Kazuharu Uchida;Takaaki Kobayashi

  • Functional Expression of the Chemokine Receptor CCR5 on Virus Epitope-Specific Memory and Effector CD8+ T Cells

    Katsuhiko Fukada;Yuji Sobao;Hiroko Tomiyama;Shinichi Oka

  • Novel Conserved-region T-cell Mosaic Vaccine With High Global HIV-1 Coverage Is Recognized by Protective Responses in Untreated Infection

    Beatrice Ondondo;Hayato Murakoshi;Genevieve Clutton;Genevieve Clutton;Sultan Abdul-Jawad

  • Impaired fatty acid utilization in thioredoxin binding protein-2 (TBP-2)-deficient mice: a unique animal model of Reye syndrome

    Shinichi Oka;Wenrui Liu;Hiroshi Masutani;Hiromi Hirata

  • Extensive gut virome variation and its associations with host and environmental factors in a population-level cohort

    Unknown

  • (1-->3) beta-D-glucan as a quantitative serological marker for Pneumocystis carinii pneumonia.

    A Yasuoka;N Tachikawa;K Shimada;S Kimura

  • Impact of small body weight on tenofovir-associated renal dysfunction in HIV-infected patients: a retrospective cohort study of Japanese patients

    Takeshi Nishijima;Hirokazu Komatsu;Hiroyuki Gatanaga;Takahiro Aoki

  • Urinary beta2-microglobulin as a possible sensitive marker for renal injury caused by tenofovir disoproxil fumarate.

    Hiroyuki Gatanaga;Natsuo Tachikawa;Yoshimi Kikuchi;Katsuji Teruya

  • Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials.

    Giuliano Rizzardini;Edgar T. Overton;Chloe Orkin;Susan Swindells

  • Polymorphism in the Interleukin-4 Promoter Affects Acquisition of Human Immunodeficiency Virus Type 1 Syncytium-Inducing Phenotype

    Emi E. Nakayama;Yoshihiko Hoshino;Xiaomi Xin;Huanliang Liu

  • Rapid and simple phenotypic assay for drug susceptibility of human immunodeficiency virus type 1 using CCR5-expressing HeLa/CD4(+) cell clone 1-10 (MAGIC-5).

    Atsuko Hachiya;Saori Aizawa-Matsuoka;Mari Tanaka;Yukiko Takahashi

Frequent Co-Authors

Satoshi Kimura
Satoshi Kimura University of Tokyo
Hideo Shinagawa
Hideo Shinagawa BioAcademia
Shigeru Kohno
Shigeru Kohno Nagasaki University
Aikichi Iwamoto
Aikichi Iwamoto Japan Agency for Medical Research and Development
Masafumi Takiguchi
Masafumi Takiguchi Kumamoto University
Hiroyuki Gatanaga
Hiroyuki Gatanaga Kumamoto University
Tomáš Hanke
Tomáš Hanke University of Oxford
Akio Adachi
Akio Adachi Kansai Medical University
Shigeo Mori
Shigeo Mori University of Tokyo
Yoshikazu Nakamura
Yoshikazu Nakamura University of Tokyo

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in microbiology, exploring related online healthcare programs can broaden career opportunities beyond the lab. Many of these programs offer flexible schedules, making it easier to balance studies and work. If you're considering public health, some of the best easiest MPH online programs to get into provide a streamlined path to advancing your skills without overly competitive admissions.

Understanding salary expectations is crucial when planning your career. For example, exploring the child specialist salary can help you assess if this specialized pathway aligns with your financial goals. These specialists often benefit from strong job growth and rewarding work environments.

Additionally, individuals with unique backgrounds should know that there are inclusive degree options. The best degrees for felons can provide a fresh start and open doors to stable careers in healthcare and science, reinforcing that higher education is accessible to many.

Overall, combining microbiology with these online degrees and understanding diverse career pathways can help you build a versatile and rewarding professional life in the healthcare and science sectors.

Best Scientists Citing Shinichi Oka

Trending Scientists

Recently Published Articles